Fungal Species: None explicitly mentioned

Clinical Mycology Today: Emerging Challenges and Opportunities

Fungal infections are becoming more common because of new medical treatments that suppress immune function, and some fungi are developing resistance to standard medications. However, exciting new antifungal drugs are in development that work in different ways and may be easier to use. The article discusses how doctors need better ways to identify patients at risk, design better clinical trials, and train more specialists to handle these increasingly complex fungal infections.

Read More »

Medical Mycology Education in Brazil: A Cross-Sectional Survey of Medical Schools

This study examined how medical schools in southern Brazil teach students about fungal infections. The researchers surveyed 19 medical schools and found that while all schools include some mycology teaching, it is not offered as a standalone course and there are significant gaps in practical training, laboratory facilities, and instructor expertise. The study highlights that despite Brazil’s burden of serious fungal infections, future doctors are often not adequately prepared to recognize and manage these diseases.

Read More »

Clinical Mycology Today: Emerging Challenges and Opportunities

Fungal infections are becoming more common due to new cancer treatments and other medical advances, while some fungal species are developing resistance to standard antifungal medications. The good news is that several new antifungal drugs are in development with better safety profiles and novel mechanisms to fight these infections. However, the field faces challenges including limited specialized mycologists and difficulty designing clinical trials to properly test new treatments.

Read More »
Scroll to Top